CAR-T(CAR-T)细胞疗法在非肿瘤性疾病中的应用
Chimeric antigen receptor T (CAR-T) cell therapy in non-oncological diseases.
CAR-T(CAR-T)细胞在血液系统恶性肿瘤中的应用推动了这种免疫治疗形式的显著进展。
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil.
CAR-T cell therapy for multiple myeloma: a practical toolkit for treatment in Brazil.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
我们相信,本文中呈现的专家见解,特别是关于 CAR-T 细胞治疗最佳患者选择和时机的见解,将加深对 CAR-T 流程的理解,并有助于在巴西为 RRMM 患者实施这种新型疗法。
CAR-T(CAR-T)细胞疗法是复发/难治性多发性骨髓瘤(RRMM)的一种新兴治疗选择,其是一个涉及多方利益相关者的多步骤过程。因此,关于实际流程的适当教育对于确保治疗成功至关重要。
一组关键意见领袖召开会议,探讨在巴西建立和运营CAR-T 中心的关键要素。针对CAR-T 细胞治疗流程中的每个步骤,专家们就基本要求达成一致,根据实践经验给出了关键建议,并考虑了尚未解答的问题。
本文针对 CAR-T 细胞治疗过程中每个步骤的常见挑战,提出了最佳实践建议和克服这些挑战的指导意见,并重点关注巴西的现状。整个过程中的关键主题是多学科团队内部以及与转诊医生的协作,以及对患者及其照护者的沟通和教育。
A group of key opinion leaders met to explore the key elements of setting up and running a CAR-T center in Brazil. For each step in the CAR-T cell therapy process, the experts agreed on basic requirements, gave their key recommendations from practical experience, and considered any remaining unanswered questions.
This paper presents best-practice recommendations and advice on how to overcome common challenges for each step in the CAR-T cell therapy process, with a focus on the current situation in Brazil. Key themes throughout the process are collaboration within the multidisciplinary team and with the referring physician, along with communication and education for patients and their caregivers.
We believe that the expert insights presented in this paper, in particular on optimal patient selection and timing of CAR-T cell therapy, will deepen understanding of the CAR-T process and aid implementation of this novel therapy for patients with RRMM in Brazil.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。